Tvardi Therapeutics, Inc.

Pharmaceutical company · Sugar Land, Texas, United States · Nasdaq: TVRD

Tvardi Therapeutics, Inc. is a pharmaceutical company headquartered in Sugar Land, Texas, United States. Its earliest recorded incorporation is in 2017. Its shares trade on Nasdaq under the ticker TVRD. It has received 1 NIH small-business research grant, $1.3 million in total. It has reported private securities offerings to the US SEC, most recently $72 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Tvardi Therapeutics at a glance

Typepharmaceutical company
HeadquartersSugar Land, Texas, United States
Earliest incorporation on record2017
Stock listingNasdaq: TVRD
SEC industryPharmaceutical Preparations

What does Tvardi Therapeutics do?

US government research funding

1 NIH small-business research grant, $1.3 million in total. NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.

Private fundraising reported to the SEC

5 Form D notices; the most recent reported $72.4 million sold (2021).

Frequently asked questions about Tvardi Therapeutics

Where is Tvardi Therapeutics headquartered?

Tvardi Therapeutics, Inc. is headquartered in Sugar Land, Texas, United States.

What does Tvardi Therapeutics do?

Tvardi Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Tvardi Therapeutics a public company?

Yes. Tvardi Therapeutics, Inc. trades on Nasdaq under the ticker TVRD.

When was Tvardi Therapeutics founded?

The earliest incorporation on record for Tvardi Therapeutics, Inc. is in 2017, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.